Palonosetron Injection 0.25 mg/5 mL (0.05 mg/mL) Suppliers & Bulk Manufacturers
Available Forms: IV Injection
Available Strengths: 0.25 mg/5 mL (0.05 mg/mL)
Reference Brands: Aloxi (US & EU)
Category: Oncology Cancer Care
Palonosetron Injection is a long-acting antiemetic used to prevent CINV and PONV, available as 0.25 mg/5 mL and 0.075 mg/mL IV doses. Marketed under Aloxi® in the US and EU, it offers extended protection and is ideal for oncology settings. GMP-compliant and available in both branded and generic forms, Palonosetron is a reliable choice for pharma partners across Europe and North America.
Product Description:
Palonosetron Injection is a next-generation 5-HT3 receptor antagonist used to prevent chemotherapy-induced and post-operative nausea and vomiting (CINV & PONV). Known for its long half-life and superior efficacy, Palonosetron provides extended protection against both acute and delayed emesis. It is available in 0.25 mg/5 mL and 0.075 mg/mL IV formulations, ideal for hospital and oncology settings. Marketed under Aloxi® in the US and EU, and also offered in generic form, it is manufactured under GMP-certified conditions. Palonosetron is a preferred antiemetic for pharmaceutical distributors seeking reliable oncology support across Europe and North America.
Palonosetron Injection — third party manufacturing & bulk supply
Palonosetron Injection 0.25 mg/5 mL (0.05 mg/mL) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Palonosetron Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Palonosetron Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Palonosetron is used to prevent nausea and vomiting associated with cancer chemotherapy and surgical procedures. It is particularly effective in preventing delayed nausea and vomiting that may occur several hours to days after treatment.
Palonosetron is a chemically synthesized compound that belongs to the class of serotonin (5-HT₃) receptor antagonists. It works by blocking serotonin receptors involved in triggering nausea and vomiting.
Palonosetron is marketed under the trade name Aloxi.
The original brand Aloxi was developed and marketed by Helsinn Healthcare. Today, palonosetron is also manufactured by multiple pharmaceutical companies worldwide as branded and generic versions.
The generic name is palonosetron (commonly used as palonosetron hydrochloride).
The most well-known brand name is Aloxi, along with various country-specific branded generics.
Palonosetron is manufactured in several countries including the USA, EU nations, India, and other regulated markets by approved pharmaceutical manufacturers following international quality and regulatory standards.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
